Some of the material in is restricted to members of the community. By logging in, you may be able to gain additional access to certain collections or items. If you have questions about access or logging in, please use the form on the Contact Page.
Oral naratriptan results in slightly fewer headache days than placebo in patients with menstrual migraines. (SOR A, based on consistent randomized controlled trials [RCTs].) Naproxen and magnesium therapy are also more effective than placebo. (SOR B, based on single small RCTs.) Frovatriptan may reduce the severity of pain better than transdermal estrogens and naproxen (SOR C, based on a single open-label comparison study), but has not been studied in comparison with a placebo.